Market Cap (In TWD)
41.73 Billion
Revenue (In TWD)
86.78 Million
Net Income (In TWD)
-1.31 Billion
Avg. Volume
2.98 Million
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 85.5-192.3869
- PE
- -
- EPS
- -
- Beta Value
- 1.554
- ISIN
- TW0004743000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Nien-Yi Chen
- Employee Count
- -
- Website
- https://www.onenessbio.com.tw
- Ipo Date
- 2011-09-23
- Details
- Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, which is in pre-clinical stage for the treatment of allergic asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. The company was incorporated in 2008 and is headquartered in Taipei City, Taiwan.
More Stocks
-
SRTTYZOZO, Inc.
SRTTY
-
CMPCEmpresas CMPC S.A.
CMPC
-
HYZNHyzon Motors Inc.
HYZN
-
AML
-
2013
-
LEDSSemiLEDs Corporation
LEDS
-
AEYGQ
-
3260